Study guide
6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
Philippine Medical Technologists Licensure Examination MTLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety
1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards
2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function
2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice
3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology
3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology
4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety
4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms
5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria
5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology
6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology
6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods
7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control
8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders
8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry
9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders
9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests
10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing
10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures
11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions
11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin
12 Chapter 12: Clinical Serology and Immunology
12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)
13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology
13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control
14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens
14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens
15 Chapter 15: Histopathologic Techniques and Cytotechnology
15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records
16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics
6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
Key Takeaways Explain This Topic AI
Enveloped viruses are inactivated by drying, detergents, and lipid solvents, while naked viruses such as enteroviruses, rotavirus, norovirus, and hepatitis A resist them.
Viral specimens are collected with synthetic swabs on plastic shafts, transported in viral transport medium at about 4 °C, and frozen at -70 °C rather than -20 °C when testing is delayed.
Dengue NS1 antigen and RT-PCR detect infection during the first 5 days of fever, while IgM becomes reliably detectable from about day 5.
Cowdry type A intranuclear inclusions suggest herpes simplex or varicella-zoster virus, owl's eye inclusions suggest cytomegalovirus, and Negri bodies suggest rabies.
In the Philippines, RITM is the DOH reference laboratory for dengue, influenza, measles, and rabies, while SACCL at San Lazaro Hospital is the reference laboratory for HIV, hepatitis, and syphilis.
Last updated: October 2026
Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
Viruses make up about 10% of the microbiology portion of the board blueprint. Viruses are obligate intracellular parasites, so the laboratory cannot grow them on ordinary media. Diagnosis depends on correct collection and transport, detection of antigen or nucleic acid, demonstration of cytopathic effect or inclusions, and serology timed to the course of infection. This section covers viral architecture, specimen handling, diagnostic methods, the clinically important respiratory, herpes, blood-borne, enteric, and arthropod-borne viruses, and HIV, followed by a reference matrix and notes on Philippine reference laboratories.
1. Viral Architecture, Specimen Handling, and Diagnostic Methods
Viruses are non-cellular obligate intracellular parasites comprising a nucleic acid genome (DNA or RNA) enclosed within a protein shell ( capsid ) composed of capsomers, arranged in helical or icosahedral (cubic) symmetry. Enveloped viruses acquire a host-derived lipid bilayer containing viral glycoprotein spikes, rendering them sensitive to heat, drying, detergents, and lipid solvents. Naked (non-enveloped) viruses possess protein capsids that resist drying, detergents, and gastric acidity (e.g., enteroviruses, rotavirus, norovirus, hepatitis A). ┌────────────────────────────────────────────────────────┐
- │ Clinical Virology Specimen Collection Protocols │
- └───────────────────────────┬────────────────────────────┘
- │
- ┌──────────────────────────────────────────┴──────────────────────────────────────────┐
- ▼ ▼
- ┌─────────────────────────────────────────┐ ┌─────────────────────────────────────────┐
- │ Swab Selection & Transport │ │ Thermal Preservation Rules │
- ├─────────────────────────────────────────┤ ├─────────────────────────────────────────┤
- │ • ACCEPTABLE: Synthetic Dacron, │ │ • Immediate processing or store at 4°C │
- │ polyester, or flocked nylon swabs on │ │ on wet ice for up to 48-72 hours │
- │ plastic or flexible aluminum shafts │ │ • If delayed >72 hours: │
- │ • STRICTLY FORBIDDEN: Calcium alginate │ │ FREEZE AT -70°C (or liquid nitrogen) │
- │ (toxic to viruses & cell culture) and │ │ • CRITICAL EXAM TRAP: NEVER FREEZE AT │
- │ wooden shafts (contain formaldehydes) │ │ -20°C! Ice crystal formation causes │
- │ • Media: Viral Transport Medium (VTM) │ │ complete loss of viral viability & │
- │ with buffered salt, protein, and Abx │ │ membrane disruption │
- └─────────────────────────────────────────┘ └─────────────────────────────────────────┘
- Diagnostic Virology Methodologies
Cell Culture & Cytopathic Effect (CPE) :
Primary Cell Cultures : Derived directly from animal tissue (e.g., Primary Rhesus Monkey Kidney, PRMK); low passage ( < 2 to 3 <2\text{ to }3 < 2 to 3 ), ideal for myxoviruses and enteroviruses.
Low-Passage Diploid Cell Lines : Capable of 20 to 50 passages, maintaining normal diploid karyotypes (e.g., Human embryonic lung fibroblasts, MRC-5, WI-38); ideal for CMV and VZV.
Continuous Immortalized Cell Lines : Indefinite propagation (e.g., HEp-2, HeLa, Vero); ideal for RSV and Adenovirus.
Cytopathic Effect Patterns : Microscopic structural changes in monolayer cells: syncytia / multinucleated giant cells (RSV, Measles, HSV), cell rounding and grape-like clustering (Adenovirus), or cell shrinkage and lysis (Enteroviruses).
Shell Vial Centrifugation Culture : Specimen is inoculated onto a low-passage cell monolayer grown on a coverslip inside a small vial. The vial is centrifuged at 700 × g 700\ \times\ g 700 × g for 45 minutes (which mechanically forces viral attachment and penetration) and incubated for 24 to 48 hours 24\text{ to }48\text{ hours} 24 to 48 hours . Viral antigens are detected via fluorescein-conjugated monoclonal antibodies long before visible CPE develops.
Molecular Real-Time RT-PCR : The contemporary gold standard for clinical virology, providing extraordinary analytical sensitivity and quantitative measurement of viral load (HIV, HCV, HBV, CMV, SARS-CoV-2).
- 2. Clinically Important Viruses: Respiratory, Herpes, Blood-Borne, Enteric, Arboviruses, and HIV
- Respiratory Viruses
Influenza Viruses (Orthomyxoviridae) : Enveloped, single-stranded negative-sense RNA genome composed of 8 distinct helical segments . Possesses two major surface glycoproteins: Hemagglutinin (HA) (mediates viral attachment to host sialic acid receptors) and Neuraminidase (NA) (cleaves sialic acid to release budding progeny virions; inhibited by oseltamivir and zanamivir).
Antigenic Drift : Minor point mutations in the genes encoding HA and NA occurring during viral replication, leading to gradual antigenic variations responsible for seasonal epidemics . Occurs in both Influenza A and Influenza B.
Antigenic Shift : Major, sudden, catastrophic genetic reassortment occurring when two distinct influenza strains (e.g., avian and human) co-infect a single animal host cell (e.g., swine), exchanging entire RNA segments. Yields novel HA or NA subtypes to which the global human population lacks immunity, resulting in worldwide pandemics . Occurs ONLY in Influenza A .
Respiratory Syncytial Virus (RSV, Pneumoviridae) : Enveloped, negative-sense ssRNA. The premier cause of severe fatal bronchiolitis and pneumonia in infants. F-protein mediates cell-to-cell fusion, forming multinucleated syncytia .
Herpesviridae: Diagnostic Inclusions and Serology
All herpesviruses feature icosahedral capsids enclosing linear double-stranded DNA and acquire an envelope from the host nuclear membrane, establishing lifelong latency.
Virus & Classification Target Latency Site Diagnostic Cellular Pathology & Microscopic Inclusions Key Clinical Syndromes & Confirmatory Tests
HSV-1 & HSV-2 ( Alphaherpesvirinae ) Sensory ganglia (trigeminal ganglia for HSV-1; sacral ganglia for HSV-2) Tzanck smear of vesicular base scraping reveals multinucleated giant cells with Cowdry A eosinophilic intranuclear inclusions Gingivostomatitis, herpes labialis, genital herpes, neonatal herpes, temporal lobe encephalitis; confirmed by PCR
Varicella-Zoster Virus (VZV) ( Alphaherpesvirinae ) Dorsal root and cranial nerve ganglia Identical to HSV: multinucleated giant cells with Cowdry A inclusions on Tzanck smear Primary: Varicella (chickenpox, lesions in all stages); Reactivation: Herpes zoster (shingles, unilateral dermatomal rash)
Epstein-Barr Virus (EBV) ( Gammaherpesvirinae ) B-lymphocytes (binds CD21 / CR2 receptor) Peripheral blood smear reveals atypical reactive lymphocytes (Downey cells) : large reactive cytotoxic CD8+ T cells Infectious Mononucleosis : Fever, exudative pharyngitis, lymphadenopathy, splenomegaly; Burkitt lymphoma, nasopharyngeal carcinoma
Cytomegalovirus (CMV) ( Betaherpesvirinae ) Monocytes, macrophages, endothelial cells Markedly enlarged cells ( cytomegaly ) containing a dense basophilic intranuclear inclusion surrounded by a clear halo ("owl's eye" appearance) Congenital sensorineural deafness and periventricular calcifications; CMV retinitis, pneumonitis, and colitis in transplant/AIDS
Infectious Mononucleosis Diagnostic Serology
Heterophile Antibodies (Paul-Bunnell / Monospot Test) :
IgM antibodies produced by non-specifically stimulated polyclonal B-cells that agglutinate sheep, horse, or bovine erythrocytes.
Davidsohn Differential Absorption Pattern :
Agglutinins of Infectious Mononucleosis are NOT absorbed by guinea pig kidney cells (antigen remains reactive; agglutination persists).
Agglutinins of Infectious Mononucleosis are COMPLETELY absorbed by beef (bovine) red blood cells (agglutination is extinguished).
(Forssman antibodies are absorbed by guinea pig kidney but not by beef RBCs; serum sickness antibodies are absorbed by both).
EBV-Specific Serology :
Anti-VCA IgM (Viral Capsid Antigen) : Indicates acute primary infection (appears early, disappears in 2 to 3 months).
Anti-VCA IgG : Emerges during acute infection and persists for life.
Anti-EBNA (Epstein-Barr Nuclear Antigen) : Appears late ( 2 to 4 months 2\text{ to }4\text{ months} 2 to 4 months post-onset) and remains positive for life; indicates past/convalescent infection.
Blood-Borne, Enteric, and Arboviruses
Rotavirus (Reoviridae) : Naked, double-shelled icosahedral capsid enclosing 11 segments of double-stranded RNA . The leading cause of severe dehydrating diarrhea in infants and young children worldwide. Diagnosed by rapid stool enzyme immunoassay (EIA) or lateral flow immunochromatography.
Dengue Virus (Flaviviridae) : Single-stranded positive-sense enveloped RNA virus possessing 4 distinct antigenically related serotypes (DEN-1, DEN-2, DEN-3, DEN-4) . Transmitted by the domestic day-biting mosquito Aedes aegypti (and Aedes albopictus ).
Diagnostic Algorithm :
Days 1 to 5 of Fever (Acute Febrile Phase) : High viremia. Diagnostic choice is Dengue Non-Structural Protein 1 (NS1) antigen detection in serum via rapid lateral flow or ELISA, alongside RT-PCR.
Day 5 Onwards (Convalescent/Critical Phase) : Viremia declines as humoral immunity emerges. Diagnostic choice shifts to anti-dengue IgM and IgG capture ELISA . Primary infection demonstrates elevated IgM by day 5; secondary infection shows rapid, massive elevation of IgG with low or variable IgM.
Critical Clinical Warning (Antibody-Dependent Enhancement - ADE) : Secondary infection with a heterologous dengue serotype triggers ADE. Pre-existing non-neutralizing IgG cross-reacts with the new serotype, enhancing viral uptake into Fc-receptor-bearing macrophages. This causes massive cytokine storms, severe vascular permeability, Dengue Hemorrhagic Fever (DHF) , and Dengue Shock Syndrome (DSS) characterized by rapid platelet destruction ( < 100 , 000 / μ L <100,000/\mu\text{L} < 100 , 000/ μ L ) and hemoconcentration (hematocrit rise ≥ 20 % \ge 20\% ≥ 20% ) .
Human Immunodeficiency Virus (HIV-1 / HIV-2)
Architecture : Enveloped retrovirus (Lentivirus) containing two identical copies of single-stranded positive-sense RNA, reverse transcriptase, integrase, and protease, enclosed in a cone-shaped capsid composed of p24 protein , surrounded by a lipid membrane with surface glycoprotein spikes ( gp120 attachment protein and gp41 transmembrane protein).
- CDC / CLSI Diagnostic Algorithm : ┌────────────────────────────────────────────────────────┐
- │ CDC/CLSI Standard HIV Laboratory Testing Algorithm │
- └───────────────────────────┬────────────────────────────┘
- │
- ▼
- ┌────────────────────────────────────────────────────────┐
- │ STEP 1: 4th-Generation HIV-1/2 Combo Immunoassay │
- │ (Detects HIV-1/2 antibodies AND free p24 antigen) │
- └───────────────────────────┬────────────────────────────┘
- │
- ┌────────────────────┴────────────────────┐
- ▼ ▼
- ┌──────────────┐ ┌──────────────┐
- │ NON-REACTIVE │ │ REACTIVE │
- └──────┬───────┘ └──────┬───────┘
- │ │
Report Negative Proceed to STEP 2:
- for HIV-1 & HIV-2 │
- ▼
- ┌────────────────────────────────────────────────────────┐
- │ STEP 2: HIV-1 / HIV-2 Antibody Differentiation Assay │
- └─────────────────────────┬──────────────────────────────┘
- │
┌──────────────────────────────────────────────────────┼──────────────────────────────────────────────────────┐
- ▼ ▼ ▼
- ┌─────────────────────────┐ ┌─────────────────────────┐ ┌─────────────────────────┐
- │ Reactive for HIV-1 │ │ Reactive for HIV-2 │ │ Non-reactive or │
- │ antibodies │ │ antibodies │ │ Indeterminate │
- └───────────┬─────────────┘ └───────────┬─────────────┘ └───────────┬─────────────┘
- │ │ │
Report: HIV-1 Positive Report: HIV-2 Positive Proceed to STEP 3:
- Qualitative or Quantitative
- HIV-1 RNA NAT (PCR)
- │
- ┌────────────────────────────────────────────────┴────────────────────────────────────────────────┐
- ▼ ▼
- ┌─────────────────────────┐ ┌─────────────────────────┐
- │ HIV-1 RNA Detected │ │ HIV-1 RNA Not Detected │
- └───────────┬─────────────┘ └───────────┬─────────────┘
- │ │
- Report: Acute Early Report: False-positive
- HIV-1 Infection initial screening test
Immunological Monitoring : Flow cytometric enumeration of C D 4 + CD4^+ C D 4 + T-helper lymphocytes ( C D 4 : C D 8 CD4:CD8 C D 4 : C D 8 ratio normally > 1.5 – 2.0 >1.5\text{--}2.0 > 1.5 – 2.0 ; inverted to < 0.5 <0.5 < 0.5 in untreated HIV). AIDS is diagnosed when the absolute C D 4 + CD4^+ C D 4 + count declines below 200 cells / μ L 200\ \text{cells}/\mu\text{L} 200 cells / μ L (or C D 4 % < 14 % CD4\% < 14\% C D 4% < 14% ), placing the patient at catastrophic risk for opportunistic infections ( Pneumocystis jirovecii , Cryptococcus neoformans , Toxoplasma gondii , Mycobacterium avium complex, and Cytomegalovirus ).
3. Clinical Virus Laboratory Reference Matrix
Viral Agent Genome & Architecture Diagnostic Specimen & Transport Premier Laboratory Methodology Pathognomonic Laboratory Features
Influenza A / B Segmented negative ssRNA (8 segments), enveloped Nasopharyngeal swab in VTM at 4°C Multiplex Real-Time RT-PCR; rapid antigen Antigenic drift (A and B) vs Antigenic shift (Influenza A only)
RSV Non-segmented negative ssRNA, enveloped Nasopharyngeal aspirate or swab in VTM Real-Time RT-PCR; rapid antigen EIA Formation of syncytia (multinucleated giant cells) in cell culture
HSV-1 & HSV-2 Linear double-stranded DNA, enveloped Vesicle fluid, swab of ulcer base in VTM Real-Time PCR (CSF, lesions); Tzanck smear Cowdry A eosinophilic intranuclear inclusions on Tzanck smear
VZV Linear double-stranded DNA, enveloped Vesicle fluid, scrapings of lesion base Real-Time PCR; DFA on vesicle cells Tzanck smear positive; dermatomal vesicular rash
EBV Linear double-stranded DNA, enveloped Serum or EDTA whole blood Monospot (heterophile Abs); anti-VCA IgM Downey cells ; heterophile agglutinins absorbed by beef RBCs
CMV Linear double-stranded DNA, enveloped EDTA whole blood, urine, BAL fluid Quantitative real-time PCR; shell vial "Owl's eye" basophilic intranuclear inclusions in cytomegaly
Rotavirus Segmented double-stranded RNA (11 segments), naked Unpreserved diarrheic stool Stool enzyme immunoassay (EIA); RT-PCR Wheel-like icosahedral symmetry; leading cause of infant dehydration
Dengue Virus Positive-sense ssRNA (4 serotypes), enveloped Serum (red top / gold SST) NS1 antigen (Days 1–5) ; IgM/IgG ELISA (Day 5+) ADE in secondary dengue; hemoconcentration ( ≥ 20 % \ge 20\% ≥ 20% ) & low platelets
HIV-1 / HIV-2 Diploid positive-sense ssRNA, enveloped retrovirus Serum or EDTA plasma 4th-Gen Combo Immunoassay → \to → Differentiation p24 antigen detects early acute infection; C D 4 < 200 / μ L CD4 < 200/\mu\text{L} C D 4 < 200/ μ L = AIDS
4. Philippine Reference Laboratories and Timing Rules
Research Institute for Tropical Medicine (RITM): The DOH national reference laboratory for many emerging and re-emerging infections, including dengue, influenza, measles and rubella, and rabies. Hospital laboratories send isolates and specimens to RITM for confirmation and surveillance.
San Lazaro Hospital STD/AIDS Cooperative Central Laboratory (SACCL): The national reference laboratory for HIV, hepatitis, and syphilis testing. HIV confirmation in the Philippines follows the DOH rapid HIV diagnostic algorithm (rHIVda), covered in the infectious disease serology section.
Dengue timing: NS1 antigen and RT-PCR detect dengue during the first 5 days of fever. Dengue IgM becomes reliably detectable from about day 5 onward, and a rising IgG (or a high IgG with a low IgM ratio) indicates secondary infection.
Rabies: The direct fluorescent antibody test on brain tissue is the reference method. Negri bodies (eosinophilic cytoplasmic inclusions in neurons) are the classic histologic sign but are not seen in every case.
Inclusion bodies at a glance: Intranuclear inclusions are typical of DNA viruses that replicate in the nucleus (Cowdry type A in herpes simplex and varicella-zoster, "owl's eye" in cytomegalovirus). Cytoplasmic inclusions are typical of most RNA viruses (Negri bodies in rabies) and of poxviruses (Guarnieri bodies).